What is Haemonetics's net income?

Haemonetics (HAE) reported net income of $44.74M in Q4 2025.

How has Haemonetics's net income changed year-over-year?

Haemonetics's net income increased by 19.3% year-over-year, from $37.49M to $44.74M.

What is the long-term trend for Haemonetics's net income?

Over 3 years (2022 to 2025), Haemonetics's net income has grown at a 56.9% compound annual growth rate (CAGR), from $43.38M to $167.68M.

What does net income mean?

The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Haemonetics HAE Net Income

Net Income at other companies

AbbottABT

$1.08B-18.7%

TFX

TeleflexTFX

-$8.15M-109%

Boston ScientificBSX

$1.34B+99.3%

MedtronicMDT

$1.24B+17.8%

LivaNovaLIVN

$22.29M+107%

ICU MedicalICUI

$30.13M+295%

Other financials

Income statement

See full

Revenue$346.4M+4.8%

Gross profit$198.2M+2.7%

Operating income$67.4M+14.2%

EPS (diluted)$0.95+28.4%

Balance sheet

See full

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

See full

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

See full

Market cap$3.37B-18.0%

Enterprise value$4.4B-12.5%

P/S2.5×-0.5×

Profitability

See full

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

See full

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Current ratio3×+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Haemonetics’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Haemonetics's net income?: Haemonetics (HAE) reported net income of $44.74M in Q4 2025.
How has Haemonetics's net income changed year-over-year?: Haemonetics's net income increased by 19.3% year-over-year, from $37.49M to $44.74M.
What is the long-term trend for Haemonetics's net income?: Over 3 years (2022 to 2025), Haemonetics's net income has grown at a 56.9% compound annual growth rate (CAGR), from $43.38M to $167.68M.
What does net income mean?: The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.